巨细胞病毒感染及巨细胞病毒血清状态与异基因造血干细胞移植受者侵袭性真菌感染的相关性:系统评价与荟萃分析
该系统评价与荟萃分析共纳入18项研究进行系统评价、12项进行荟萃分析,评估异基因造血干细胞移植受者移植后巨细胞病毒感染及血清状态与侵袭性真菌感染的关系。作者认为需进一步研究识别高危受者并聚焦真菌诊断与预防。
核心结论
- 移植后巨细胞病毒感染和高危巨细胞病毒血清状态增加异基因造血干细胞移植受者侵袭性真菌感染风险,低危血清状态降低风险。
- 作者认为需进一步研究识别高危异基因造血干细胞移植受者,并聚焦真菌诊断与预防以阻止病毒后真菌现象。
研究设计与样本
- 系统评价与荟萃分析,检索Medline、Embase和ISI Web of Science数据库自建库至2021年7月11日。
- 纳入横断面、前瞻性队列、回顾性队列和病例对照研究,报告异基因造血干细胞移植受者巨细胞病毒感染后发生或不发生侵袭性真菌感染。
- 共18项研究纳入系统评价,12项纳入荟萃分析;两名评价员独立筛选、提取数据并评估研究质量,采用纽卡斯尔-渥太华量表评估偏倚风险,使用随机效应模型合并效应估计。
主要发现
- 按侵袭性真菌感染发生时间、巨细胞病毒定义、研究所在洲、研究设计和效应估计调整进行亚组分析,移植后巨细胞病毒感染均持续增加后续侵袭性真菌感染风险。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 移植后巨细胞病毒感染与侵袭性真菌感染关联的合并分析异质性I²=75%。
- 作者指出需进一步研究识别高危异基因造血干细胞移植受者,并聚焦真菌诊断与预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In allogeneic haematopoietic stem cell transplant (allo-HSCT) recipients, the inter-relationship between post-transplant cytomegalovirus (CMV) and subsequent invasive fungal infections (IFIs) is conflicting and the association of CMV serostatus with IFIs has not been evaluated. OBJECTIVES: To determine the relationship between CMV infection/serostatus and IFIs in allo-HSCT populations. DATA SOURCES: A systematic literature search was conducted from existence until 11 July 2021 using Medline, Embase and ISI Web of Science databases. STUDY ELIGIBILITY CRITERIA: Cross-sectional, prospective cohort, retrospective cohort and case-control studies that reported allo-HSCT recipients with CMV and without CMV who developed or did not develop IFIs after CMV infection. PARTICIPANTS: Allo-HSCT recipients. INTERVENTIONS: Not applicable. METHODS: A systematic search, screening, data extracting and assessing study quality were independently conducted by two reviewers. The Newcastle-Ottawa scale was used to assess risk of bias. data were analysed using the pooled effect estimates of a random-effects model. RESULTS: A total of 18 and 12 studies were included for systematic review and meta-analysis, respectively. Post-transplant CMV infection significantly increased the risk of IFIs with a pooled hazard ratio (pHR) of 2.58 (1.78, 3.74), I2 = 75%. Further subgroup analyses by timing of IFIs, CMV definitions, study continents, study design and adjustment of effect estimates showed that post-transplant CMV infection consistently increased the risk of subsequent IFIs. High-risk CMV serostatus (D-/R+) increased the risk of IFIs with a pooled odds ratio (OR) of 1.33 (1.04, 1.71), I2 = 0%, but low-risk CMV serostatus (D-/R-) decreased the risk of IFIs with a pOR of 0.69 (0.55, 0.87), I2 = 0%. CONCLUSIONS: Post-transplant CMV infection and high-risk CMV serostatus increased the risk of IFIs, but low-risk CMV serostatus decreased risk of IFIs among allo-HSCT recipients. Further studies are needed to identify at-risk allo-HSCT recipients as well as to focus on fungal diagnostics and prophylaxis to prevent this fungal-after-viral phenomenon.
引用
- Chuleerarux N, Nematollahi S, Thongkam A, et al. The association of cytomegalovirus infection and cytomegalovirus serostatus with invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients: a systematic review and meta-analysis. Clin Microbiol Infect. 2021. PMID: 34752926. doi:10.1016/j.cmi.2021.10.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。